China SXT Pharmaceuticals (SXTC) Raw Materials (2021 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Raw Materials of $276999.0 for Q1 2026, down 36.44% year-over-year from $435799.0 in Q1 2025, and down 6.9% quarter-over-quarter from $297544.0 in Q3 2025.
China SXT Pharmaceuticals (SXTC) Raw Materials (2021 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Raw Materials history runs 6 years deep, the most recent figure standing at $276999.0 for Q1 2026.
- In Q1 2026, Raw Materials fell 36.44% year-over-year to $276999.0; the TTM figure through Mar 2026 stood at $276999.0 (down 36.44% YoY), while the FY2026 annual figure was $276999.0, down 36.44% from the prior year.
- Raw Materials for Q1 2026 stood at $276999.0, down from $297544.0 in the prior quarter.
- The five-year high for Raw Materials was $604850.0 in Q1 2022, with the low at $192702.0 in Q3 2022.
- The 5-year median for Raw Materials is $309133.0 (2024), against an average of $340083.2.
- The sharpest annual moves came in 2022 and 2023: Raw Materials soared 71.26% in 2022, then tumbled 59.79% in 2023.
- China SXT Pharmaceuticals' Raw Materials stood at $192702.0 in 2022, then advanced by 26.22% to $243222.0 in 2023, then surged by 43.42% to $348828.0 in 2024, then decreased by 14.7% to $297544.0 in 2025, then retreated by 6.9% to $276999.0 in 2026.
- Business Quant data shows SXTC's Raw Materials at $276999.0 in Q1 2026, $297544.0 in Q3 2025, and $435799.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | China SXT Pharmaceuticals | 32,922.00 | -28.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 276,999.00 |
| Sep 30, 2025 | 297,544.00 |
| Mar 31, 2025 | 435,799.00 |
| Sep 30, 2024 | 348,828.00 |
| Mar 31, 2024 | 320,722.00 |
| Mar 31, 2023 | 243,222.00 |
| Sep 30, 2022 | 192,702.00 |
| Mar 31, 2022 | 604,850.00 |
| Sep 30, 2021 | 335,235.00 |
| Mar 31, 2021 | 353,174.00 |